Cibinetide was engineered to keep erythropoietin’s tissue-protective signalling while abandoning its blood-building job. The molecular logic is elegant; the human evidence, gathered mostly in small neuropathy trials, is real but early.
Humans carry a single cathelicidin. It kills microbes, calls in immune cells and helps wounds close — and, in the wrong context, teaches the immune system to attack its owner. A look at the most genuinely double-edged peptide in innate immunity.
A 28-residue thymic peptide is licensed for hepatitis across dozens of countries and drew attention during COVID-19, yet remains unapproved by the FDA. The evidence is real, large, and frustratingly uneven.
Cookies
We use strictly necessary cookies to run the store. With your consent we also use analytics (order attribution) and marketing (Omnisend) cookies. Read our Cookie Policy.